GALT - Galectin Therapeutics Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.00
DETAILS
HIGH:
$11.00
LOW:
$11.00
MEDIAN:
$11.00
CONSENSUS:
$11.00
UPSIDE:
120.44%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 2.42 |
| Quick Ratio | 2.42 |
| Solvency Ratio | -0.211 |
| Cash Ratio | 2.21 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-8.67
Peers avg: 10.1
|
| PEG Ratio | 0.24 |
| Forward PEG | 0.24 |
| Price/Book | -2.11 |
| Price/Sales | 0.00 |
| Price/FCF | -11.13 |
| Price/Op Cash Flow | -11.13 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 6.8481 |
| Debt/Equity | -1.0599 |
| Debt/Capital | 17.6880 |
| Long-Term Debt/Capital | 17.7367 |
| Financial Leverage | -0.15 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -2.973 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -3.20 |
| Interest Coverage | -2.7405 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -0.18 |
| Capital Expenditure Coverage | 0.00 |
| Dividend + Capital Expenditure Coverage | 0.00 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -0.483 |
| Debt/Share | 2.2078 |
| Cash/Share | 0.28 |
| Book Value/Share | -1.97 |
| Tangible BV/Share | -1.97 |
| Equity/Share | -1.97 |
| Operating Cash Flow/Share | -0.374 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -0.374 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.535 |
| Price/Fair Value | -2.11 |
| Debt/Market Cap | 0.5031 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -16.28 |